Posts in tag

TGA


Vitamin batch recalled due to possible incorrect tablet inclusion A single batch of Betamin 100 mg vitamin B1 tablets is being recalled by the TGA, in collaboration with manufacturer Sanofi. …

Regulator warns of safety issues after reports from pharmacies The TGA has issued a safety alert about an EpiPen Adrenaline Auto-injector produced by Alphapharm following reports from pharmacies in a …

Today in our news roundup: warnings over the timing of TGA staff cuts, and more revelations about big pharma’s business practices No time for cutbacks Revelations that the TGA plans …

Rescheduling review announced by department as May decision date looms A decision on the controversial rescheduling of codeine is expected by May 2016, following a safety review, Department of Health …

ASMI says consumers should only purchase complementary medicines approved for supply in Australia because they are highly regulated by the TGA. “Australia’s system of regulating complementary medicines is one of …

The TGA has recommended that naloxone minijet be scheduled to Pharmacist Only medicine—a decision which will likely save lives, says Angelo Pricolo, the Brunswick pharmacist who made the submission. This …

The Pharmacy Guild of Australia has expressed concern at the proposed re-scheduling of codeine containing analgesics to Schedule 4, Prescription Only Medicine. The interim decision of the Advisory Committee on …

Health Minister Sussan Ley has criticised pharmaceutical companies for dragging their feet on bringing new drugs to the Australian market and prioritising applying to lucrative markets overseas. “Australia has a …

The 2015 PricewaterhouseCoopers survey of the Australian medicines industry provides an important and timely insight into the challenges and opportunities confronting the Australian innovative medicines industry, says Medicines Australia. The …

TGA regulation, price pressure and compliance issues are reducing access to medicines, and reducing industry confidence, a PwC report claims. Challenges and Change—a report on the Australian pharmaceutical industry, released …

The TGA has advised that more children’s medicines are being recalled, because they have been supplied in bottles where grooves that secure the lids can break off during opening. The …

ASMI has said country of origin statements, graphics and visual representations should not be mandatory for therapeutic goods labels, in its submission to the Government’s review of country of origin …